No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use
-
Biomarkers, Tumor / analysis*
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology
-
Disease Progression
-
Female
-
Humans
-
Immunohistochemistry / standards
-
In Situ Hybridization, Fluorescence / standards
-
Predictive Value of Tests
-
Prognosis
-
Quality Assurance, Health Care
-
Receptor, ErbB-2 / analysis*
-
Receptor, ErbB-2 / metabolism
-
Reproducibility of Results
-
Risk Assessment
-
Surveys and Questionnaires
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Receptor, ErbB-2
-
Trastuzumab